Virtual Biotech Uses AI Agents to Find Lung Cancer Drug

A virtual biotech company has used thousands of artificial intelligence scientist agents to work on drug discovery, successfully finding a promising lung-cancer drug. This new approach aims to speed up drug research by letting AI agents collaborate and streamline the process. Major publications report that this virtual biotech system could transform how new medicines are found and tested. The method relies on putting large numbers of AI agents to work together on complex medical tasks.